Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Rationale for mass antibiotic distribution for trachoma elimination.

Gaynor BD, Yi E, Lietman T.

Int Ophthalmol Clin. 2002 Winter;42(1):85-92. Review. No abstract available.

PMID:
12189619
2.

Global elimination of trachoma: how frequently should we administer mass chemotherapy?

Lietman T, Porco T, Dawson C, Blower S.

Nat Med. 1999 May;5(5):572-6.

PMID:
10229236
3.

Antibiotic therapy for trachoma.

[No authors listed]

Prescrire Int. 2009 Aug;18(102):176-7.

PMID:
19750586
4.

A rationale for continuing mass antibiotic distributions for trachoma.

Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, Lakew T, Yi E, House J, Chidambaram JD, Whitcher JP, Gaynor BD, Lietman TM.

BMC Infect Dis. 2007 Aug 7;7:91.

5.

Towards the global elimination of trachoma.

Taylor H.

Nat Med. 1999 May;5(5):492-3. No abstract available.

PMID:
10229224
6.

Eliminating blinding trachoma.

Cook JA.

N Engl J Med. 2008 Apr 24;358(17):1777-9. doi: 10.1056/NEJMp0708546. No abstract available.

7.

Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.

Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM.

Ophthalmology. 2009 Nov;116(11):2047-50. doi: 10.1016/j.ophtha.2009.04.041. Epub 2009 Sep 10.

PMID:
19744717
8.

WHO alliance for the global elimination of blinding trachoma and the potential use of azithromycin.

Négrel AD, Mariotti SP.

Int J Antimicrob Agents. 1998 Nov;10(4):259-62. Review. No abstract available.

PMID:
9916898
9.

Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.

Stare D, Harding-Esch E, Munoz B, Bailey R, Mabey D, Holland M, Gaydos C, West S.

Ophthalmic Epidemiol. 2011 Feb;18(1):20-9. doi: 10.3109/09286586.2010.545500.

PMID:
21275593
10.

Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.

Schémann JF, Guinot C, Traore L, Zefack G, Dembele M, Diallo I, Traore A, Vinard P, Malvy D.

Acta Trop. 2007 Jan;101(1):40-53. Epub 2006 Dec 16.

PMID:
17239332
11.

Mass treatment of trachoma with azithromycin 1.5% eye drops in the Republic of Cameroon: feasibility, tolerance and effectiveness.

Huguet P, Bella L, Einterz EM, Goldschmidt P, Bensaid P.

Br J Ophthalmol. 2010 Feb;94(2):157-60. doi: 10.1136/bjo.2009.161513. Epub 2009 Aug 18.

12.

Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.

Fry AM, Jha HC, Lietman TM, Chaudhary JS, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF.

Clin Infect Dis. 2002 Aug 15;35(4):395-402. Epub 2002 Jul 23.

13.

Eliminating trachoma in areas with limited disease.

Gaynor BD, Miao Y, Cevallos V, Jha H, Chaudary JS, Bhatta R, Osaki-Holm S, Yi E, Schachter J, Whitcher JP, Lietman T.

Emerg Infect Dis. 2003 May;9(5):596-8.

14.

New steps toward eliminating blinding trachoma.

Mariotti SP.

N Engl J Med. 2004 Nov 4;351(19):2004-7. No abstract available.

PMID:
15525727
15.

Azithromycin treatment levels inadequate for recommended trachoma control guidelines.

Kelaher M, Ferdinand AS, Taylor HR.

Med J Aust. 2011 Jan 17;194(2):102. No abstract available.

PMID:
21241228
16.

[Chlamydial diseases of the eye. A short overview].

Behrens-Baumann W.

Ophthalmologe. 2007 Jan;104(1):28-34. Review. German.

PMID:
17216415
17.

Acceptability of azithromycin for the control of trachoma in Northern Tanzania.

Desmond N, Solomon AW, Massae PA, Lema N, Anemona A, Foster A, Mabey DC.

Trans R Soc Trop Med Hyg. 2005 Sep;99(9):656-63.

PMID:
15979657
18.

Trachoma and antibiotic use: the 'A' in SAFE.

West S.

Expert Rev Anti Infect Ther. 2012 Jan;10(1):75-83. doi: 10.1586/eri.11.150. Review.

PMID:
22149616
19.

The global elimination of blinding trachoma: progress and promise.

Kumaresan JA, Mecaskey JW.

Am J Trop Med Hyg. 2003 Nov;69(5 Suppl):24-8. Review.

20.

Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.

West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.

Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1492-7.

PMID:
17389476
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk